A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy

Matti Aapro, A. Macciocchi, Florian Lordick et al.|Annals of Oncology|2006

Cited by 340